COMMUNIQUÉS West-GlobeNewswire

-
Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast
07/08/2024 -
Elutia Announces Second Quarter 2024 Results
07/08/2024 -
Generation Bio Reports Second Quarter 2024 Financial Results
07/08/2024 -
Relmada Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
07/08/2024 -
Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
07/08/2024 -
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
07/08/2024 -
Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update
07/08/2024 -
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
07/08/2024 -
Keros Therapeutics Reports Second Quarter 2024 Financial Results
07/08/2024 -
electroCore Announces Second Quarter 2024 Financial Results
07/08/2024 -
LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
07/08/2024 -
Assertio Reports Second Quarter 2024 Financial Results
07/08/2024 -
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
07/08/2024 -
Angiex Announces First Patient Dosed in Phase 1 Clinical Trial of AGX101, a novel TM4SF1-Directed Antibody-Drug Conjugate for the Treatment of Solid Tumors
07/08/2024 -
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
07/08/2024 -
XYMOGEN XPERIENCE Dedicated Exclusively to Elevating Women’s Health
07/08/2024 -
Asensus Surgical 2024 Special Meeting of Stockholders Is Adjourned
07/08/2024 -
Zevra Therapeutics to Present at Canaccord Genuity’s 44th Annual Growth Conference
07/08/2024 -
Groundbreaking Voice of the Patient Report for pediatric low-grade glioma (pLGG) published by Pediatric Brain Tumor Foundation
07/08/2024
Pages